ScoreWhy is Glaxosmithkline Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 3.76% and Operating profit at 14.79% over the last 5 years
2
With ROE of 55.8, it has a Very Expensive valuation with a 26.1 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -1.52%, its profits have risen by 17.8% ; the PEG ratio of the company is 2.5
3
Underperformed the market in the last 1 year
- Even though the market (BSE500) has generated returns of 13.64% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -1.52% returns
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Glaxosmi. Pharma for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Glaxosmi. Pharma
-1.45%
-0.04
32.88%
Sensex
10.94%
0.94
11.62%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.76%
EBIT Growth (5y)
14.79%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-1.19
Sales to Capital Employed (avg)
2.02
Tax Ratio
26.63%
Dividend Payout Ratio
91.89%
Pledged Shares
0
Institutional Holding
12.34%
ROCE (avg)
-196.73%
ROE (avg)
59.34%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
44
Industry P/E
32
Price to Book Value
26.12
EV to EBIT
34.81
EV to EBITDA
32.97
EV to Capital Employed
-134.11
EV to Sales
11.20
PEG Ratio
2.50
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
55.83%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend10What is working for the Company
ROCE(HY)
Highest at 74.49%
NET SALES(Q)
Highest at Rs 1,041.26 cr
PBDIT(Q)
Highest at Rs 371.34 cr.
OPERATING PROFIT TO NET SALES(Q)
Highest at 35.66%
PBT LESS OI(Q)
Highest at Rs 349.83 cr.
PAT(Q)
Highest at Rs 282.33 cr.
EPS(Q)
Highest at Rs 17.45
-3What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 11.14 times
CASH AND CASH EQUIVALENTS(HY)
Lowest at Rs 747.83 cr
Loading Valuation Snapshot...
Here's what is working for Glaxosmi. Pharma
Net Sales - Quarterly
Highest at Rs 1,041.26 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Operating Profit (PBDIT) - Quarterly
Highest at Rs 371.34 cr.
in the last five quartersMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (Rs Cr)
Operating Profit Margin - Quarterly
Highest at 35.66%
in the last five quartersMOJO Watch
Company's efficiency has improved
Operating Profit to Sales
Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 349.83 cr.
in the last five quartersMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 349.83 cr has Grown at 22.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 285.99 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 282.33 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 17.45
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Here's what is not working for Glaxosmi. Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 11.14 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Cash and Cash Equivalents - Half Yearly
Lowest at Rs 747.83 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
